Ranibizumab 0.5 mg for Diabetic Macular Edema with Bimonthly Monitoring after a Phase of Initial Treatment
Titel:
Ranibizumab 0.5 mg for Diabetic Macular Edema with Bimonthly Monitoring after a Phase of Initial Treatment
Auteur:
Pearce, Ian Banerjee, Sanjiv Burton, Ben J.L. Chakravarthy, Usha Downey, Louise Gale, Richard P. Gibson, Jonathan Pagliarini, Sergio Patel, Jignesh Sivaprasad, Sobha Andrews, Chris Brittain, Christopher Warburton, James